Sanara MedTech Statistics
Total Valuation
Sanara MedTech has a market cap or net worth of $154.28 million. The enterprise value is $185.90 million.
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026, before market open.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Sanara MedTech has 9.17 million shares outstanding. The number of shares has increased by 1.64% in one year.
| Current Share Class | 9.17M |
| Shares Outstanding | 9.17M |
| Shares Change (YoY) | +1.64% |
| Shares Change (QoQ) | -5.23% |
| Owned by Insiders (%) | 30.84% |
| Owned by Institutions (%) | 26.91% |
| Float | 3.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 105.19 |
| PS Ratio | 1.50 |
| Forward PS | 1.28 |
| PB Ratio | 25.36 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 71.39 |
| P/OCF Ratio | 22.73 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 15.74, with an EV/FCF ratio of 86.02.
| EV / Earnings | n/a |
| EV / Sales | 1.80 |
| EV / EBITDA | 15.74 |
| EV / EBIT | 20.33 |
| EV / FCF | 86.02 |
Financial Position
The company has a current ratio of 1.80, with a Debt / Equity ratio of 8.13.
| Current Ratio | 1.80 |
| Quick Ratio | 1.53 |
| Debt / Equity | 8.13 |
| Debt / EBITDA | 3.90 |
| Debt / FCF | 22.30 |
| Interest Coverage | 1.35 |
Financial Efficiency
Return on equity (ROE) is -1.75% and return on invested capital (ROIC) is 9.12%.
| Return on Equity (ROE) | -1.75% |
| Return on Assets (ROA) | 7.10% |
| Return on Invested Capital (ROIC) | 9.12% |
| Return on Capital Employed (ROCE) | 16.84% |
| Weighted Average Cost of Capital (WACC) | 10.49% |
| Revenue Per Employee | $954,796 |
| Profits Per Employee | -$347,802 |
| Employee Count | 108 |
| Asset Turnover | 1.28 |
| Inventory Turnover | 2.24 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.44% in the last 52 weeks. The beta is 1.10, so Sanara MedTech's price volatility has been higher than the market average.
| Beta (5Y) | 1.10 |
| 52-Week Price Change | -39.44% |
| 50-Day Moving Average | 19.45 |
| 200-Day Moving Average | 25.53 |
| Relative Strength Index (RSI) | 37.15 |
| Average Volume (20 Days) | 72,584 |
Short Selling Information
The latest short interest is 216,973, so 2.37% of the outstanding shares have been sold short.
| Short Interest | 216,973 |
| Short Previous Month | 216,797 |
| Short % of Shares Out | 2.37% |
| Short % of Float | 5.72% |
| Short Ratio (days to cover) | 4.03 |
Income Statement
In the last 12 months, Sanara MedTech had revenue of $103.12 million and -$37.56 million in losses. Loss per share was -$4.36.
| Revenue | 103.12M |
| Gross Profit | 95.60M |
| Operating Income | 9.15M |
| Pretax Income | -393,124 |
| Net Income | -37.56M |
| EBITDA | 11.81M |
| EBIT | 9.15M |
| Loss Per Share | -$4.36 |
Full Income StatementBalance Sheet
The company has $16.58 million in cash and $48.19 million in debt, with a net cash position of -$31.61 million or -$3.45 per share.
| Cash & Cash Equivalents | 16.58M |
| Total Debt | 48.19M |
| Net Cash | -31.61M |
| Net Cash Per Share | -$3.45 |
| Equity (Book Value) | 5.93M |
| Book Value Per Share | 0.66 |
| Working Capital | 14.92M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $6.79 million and capital expenditures -$4.63 million, giving a free cash flow of $2.16 million.
| Operating Cash Flow | 6.79M |
| Capital Expenditures | -4.63M |
| Depreciation & Amortization | 2.66M |
| Net Borrowing | 12.25M |
| Free Cash Flow | 2.16M |
| FCF Per Share | $0.24 |
Full Cash Flow StatementMargins
Gross margin is 92.71%, with operating and profit margins of 8.87% and -36.43%.
| Gross Margin | 92.71% |
| Operating Margin | 8.87% |
| Pretax Margin | -0.38% |
| Profit Margin | -36.43% |
| EBITDA Margin | 11.45% |
| EBIT Margin | 8.87% |
| FCF Margin | 2.10% |
Dividends & Yields
Sanara MedTech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.64% |
| Shareholder Yield | -1.64% |
| Earnings Yield | -24.35% |
| FCF Yield | 1.40% |
Analyst Forecast
The average price target for Sanara MedTech is $36.00, which is 113.90% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $36.00 |
| Price Target Difference | 113.90% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 10, 2019. It was a reverse split with a ratio of 1:100.
| Last Split Date | May 10, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:100 |
Scores
Sanara MedTech has an Altman Z-Score of 3 and a Piotroski F-Score of 5.
| Altman Z-Score | 3 |
| Piotroski F-Score | 5 |
